Release date: 2015-12-10
For a long time, the domestic medical device field has always been a foreign-owned brand, and with the intervention of capital and the encouragement of policies, the industry is undergoing subtle changes. Shi Yonghui, head of investment and mergers and acquisitions department of Medtronic, Greater China, a global orthopaedic medical device giant, believes that the rectification of illegal activities by foreign-funded enterprises is of great benefit to the regulation of the entire medical industry.
China's medical device companies will not reproduce the high growth rate of 30% in previous years, but compared with developed markets in Europe and America, there is still huge room for growth. In particular, as the country encourages domestic medical devices to improve performance and upgrade, it will bring more rapid development opportunities to China's medical device industry.
In this context, the recent China Heart and Cerebrovascular Devices Industry and Investment CEO Summit attracted the participation of industry authorities such as medical device listed companies, industry associations, institutional investors, and brokerage researchers.
Pu Zhongjie, Chairman of Lepu Medical, told the reporter that the cardiovascular and cerebrovascular medical device industry in China faces four major development opportunities. First of all, in terms of degradable cardiac stents, there is a small gap between China's technical level and international level, and there is an opportunity to participate in international competition and go global. In the next 3-5 years, the entry of Chinese companies will lead to the global market for degradable heart stents.
Secondly, in the device market such as pacemakers, it is currently in the state of being monopolized by foreign-funded enterprises. Domestically produced devices only have a 12% share. Under the background of the country's encouragement of domestic medical device upgrades and government procurement, the opportunities for substitution of domestically produced devices are large. increase.
Third, in terms of three-dimensional mapping equipment, although the capacity of the market segment is small, the growth rate is fast; finally, there is a great opportunity for prevention testing. "In view of the fact that there are 200 million people with high blood pressure in China and 100 million people with diabetes, the trend of shortage of medical resources in China is difficult to change for a long time, so the opportunities for prevention and testing of products are also prosperous." He mentioned such as implantable monitoring. Devices, in vitro ECG monitoring technology and services are expected to receive more attention.
Yang Rui, general manager of BOC International Investment Banking Department, said that from the development path of medical equipment giants such as Medtronic, the main reason is to continue to grow bigger and stronger. At present, China's medical device industry is also replicating the growth path of foreign giants.
Source: Fuyi Smart Medical
Alcohol Spray,Spray Hand Sanitizer,Hand Sanitizer Alcohol,Hand Sanitizer Liquid
Wuxi Keni Daily Cosmetics Co.,Ltd , https://www.kenicosmetics.com